Dengue hemorrhagic fever and shock syndromes

Pediatric Critical Care Medicine

Volumn 12, Issue 1, 2011, Pages 90-100

  Ranjit, Suchitra ^a   Kissoon, Niranjan ^b  

^a Apollo Children's Hospital   (India)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

children; critical illness; dengue hemorrhagic fever; dengue shock syndrome; diagnosis; immunopathogenesis; management; shock

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 7; DENGUE VACCINE; DIURETIC AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN D ANTIBODY; INOTROPIC AGENT; NEUTRALIZING ANTIBODY; SINGLE STRANDED RNA;

AEDES AEGYPTI; ANTIBIOTIC THERAPY; APOPTOSIS; ARTICLE; ASIA; BLEEDING; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL VENOUS PRESSURE; CHILDHOOD MORTALITY; DENGUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; FLAVIVIRUS; FLUID THERAPY; GEOGRAPHIC DISTRIBUTION; HEART DISEASE; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOPATHOGENESIS; KIDNEY FAILURE; LABORATORY TEST; LUMBAR PUNCTURE; LUNG EDEMA; MOLECULAR DIAGNOSIS; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PRIMARY INFECTION; PRIORITY JOURNAL; PROGNOSIS; REHYDRATION; SECONDARY INFECTION; SEPTIC SHOCK; SERODIAGNOSIS; SHOCK; SOUTH AMERICA; T LYMPHOCYTE ACTIVATION; THROMBOCYTOPENIA; TOURNIQUET; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 78751649070     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181e911a7     Document Type: Review

References (73)

1. World Health Organization: Dengue Hemor-rhagic Fever: Diagnosis, Treatment, Prevention and Control. Second Edition. Geneva, World Health Organization, 1997
2. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Third Edition. A joint publication of the World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, 2009
3. Gubler DJ: Dengue/dengue hemorrhagic fever: History and current status. Novartis Found Symp 2006; 277:3-16
4. Centers for Disease Control and Prevention: Dengue. Available at http://www.cdc.gov/ NCIDOD/DVBID/DENGUE. Accessed September 2008
5. Pinheiro FP, Corber SJ: Global situation of dengue and dengue hemorrhagic fever and its emergence in the Americas. World Health Stat Q 1997; 50:161-168
6. Gubler DJ: Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480-496
7. World Health Organization: Scientific working group on dengue, Geneva, 2006. Available at http://www.who.int/tdr/svc/publications/tdr-research- publications/swg-report-dengue. Accessed March 2009
8. Halstead SB: Is there an inapparent dengue explosion? Lancet 1999; 353:1100-1101
9. Guzmán MG, Kourí G: Dengue: An update. Lancet Infect Dis 2002; 2:33-42
10. Teo D, Ng LC, Lam S: Is dengue a threat to the blood supply? Transfus Med 2009; 19: 66-77
11. Malavige GN, Fernando S, Fernando DJ: Dengue viral infections. Postgrad Med J 2004; 80:588-601
12. Halstead SB: Dengue. Lancet 2007; 370: 1644-1652
13. Vaughn DW, Green S, Kalayanarooj S, et al: Dengue in the early febrile phase: Viremia and antibody responses. J Infect Dis 1997; 176:322-330
14. Rothman AL: Pathogenesis of dengue virus infection, UpToDate 2008. Available at http:// www.Uptodate.com. Accessed September 2008
15. Shirtcliffe P, Cameron E, Nicholson KG, et al: Don't forget dengue! Clinical features of dengue fever in returning travellers. J R Coll Physicians Lond 1998; 32:235-237
16. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al: Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003; 9:921-927
17. Rothman AL: Dengue: Defining protective versus pathologic immunity. J Clin Invest 2004; 113:946-951
18. Guzman MG, Alvarez M, Rodriguez-Roche R, et al: Neutralizing antibodies after infection with dengue 1 virus. Emerg Infect Dis 2007; 13:282-286
19. Morens DM: Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 1994; 19: 500-512
20. Vaughn DW, Green S, Kalayanarooj S, et al: Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181:2-9
21. Binh PT, Matheus S, Huong VT, et al: Early clinical and biological features of severe clinical manifestations of dengue in Vietnamese adults. J Clin Virol 2009; 45:276-280
22. Nguyen TH, Lei HY, Nguyen TL, et al: Dengue hemorrhagic fever in infants: A study of clinical and cytokine profiles. J Infect Dis 2004; 189:221-232
23. Kliks SC, Nimmanitya S, Nisalak A, et al: Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988; 38:411-419
24. Thisyakorn U, Nimmannitya S: Nutritional status of children with dengue hemorrhagic fever. Clin Infect Dis 1993; 16:295-297
25. Bandyopadhyay S, Lum LC, Kroeger A: Classifying dengue: A review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health 2006; 11:1238-1255
26. Rigau-Pérez JG: Severe dengue: The need for new case definitions. Lancet Infect Dis 2006; 6:297-302
27. Deen JL, Harris E, Wills B, et al: The WHO dengue classification and case definitions: Time for a reassessment. Lancet 2006; 368: 170-173
28. TDR: World Health Organization issues new dengue guidelines. Available at http:// apps.who.int/tdr/svc/publications/tdrnews/ issue-85/tdr-briefly. Accessed July 1, 2010
29. Wills BA, Oragui EE, Stephens AC, et al: Coagulation abnormalities in dengue hemor-rhagic fever: Serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis 2002; 35:277-285
30. Gomber S, Ramachandran VG, Satish Kumar KN, et al: Hematological observations as diagnostic markers in dengue hemorrhagic fever: A reappraisal. Indian Pediatr 2001; 38: 477-481
31. Khongphatthanayothin A, Suesaowalak M, Muangmingsook S, et al: Hemodynamic profiles of patients with dengue hemorrhagic fever during toxic stage: An echocardio-graphic study. Intensive Care Med 2003; 29: 570-574
32. Rothman AL: Clinical presentation and diagnosis of dengue virus infections UpToDate 2008. Available at http://www.Uptodate.com. Accessed September 2008
33. Kabra SK, Jain Y, Pandey RM, et al: Dengue hemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg 1999; 93:294-298
34. Srichaikul T, Nimmanitaya S, Artchararit N, et al: Fibrinogen metabolism and disseminated intravascular coagulation in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26:525-532
35. Mitrakul C, Poshyachinda M, Futrakul P, et al: Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26:975-984
36. Lum LCS, Goh AYT, Chan PWK, et al: Risk factors for hemorrhage in severe dengue infections. J Pediatr 2002; 140:629-631
37. Nimmannitya S, Thisyakorn U, Hemsrichart V: Dengue haemorrhagic fever with unusual manifestations. Southeast Asian J Trop Med Public Health 1987; 18:398-406
38. Kamath SR, Ranjit S: Clinical features, complications and atypical manifestations of children with severe forms of dengue hemor-rhagic fever in South India. Indian J Pediatr 2006; 73:889-895
39. Solomon T, Dung NM, Vaughn DW, et al: Neurological manifestations of dengue infection. Lancet 2000; 355:1053-1059
40. Lum LC, Lam SK, Choy YS, et al: Dengue encephalitis: A true entity? Am J Trop Med Hyg 1996; 54:256-259
41. Wali JP, Biswas A, Chandra S, et al: Cardiac involvement in dengue haemorrhagic fever. Int J Cardiol 1998; 64:31-36
42. Kabra SK, Juneja R, Madhulika, et al: Myo-cardial dysfunction in children with dengue haemorrhagic fever. Natl Med J India 1998; 11:59-61
43. Khongphatthanayothin A, Lertsapcharoen P, Supachokchaiwattana P, et al: Myocardial depression in dengue hemorrhagic fever: Prevalence and clinical description. Pediatr Crit Care Med 2007; 8:524-529
44. Ranjit S, Kissoon N, Jayakumar I: Aggressive management of dengue shock syndrome may decrease mortality rate: A suggested protocol. Pediatr Crit Care Med 2005; 6:412-419
45. Srichaikul T, Punyagupta S, Kanchanapoom T: Hemophagocytic syndrome in dengue hemorrhagic fever with severe multiorgan complications. J Med Assoc Thai 2008; 91: 104-109
46. Khilnani P, Sarma D, Zimmerman J, et al: Epidemiology and peculiarities of pediatric multiple organ dysfunction syndrome in New Delhi. India Intensive Care Med 2006; 32: 1856-1862
47. Khilnani P, Sarma D, Singh R, et al: Demographic profile and outcome analysis of a tertiary level pediatric intensive care unit. Indian J Pediatr 2004; 71:587-591
48. De Paula SO, da Fonseca BAL: Dengue: A review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis 2004; 8:390-398
49. Ramos M, Tomashek K, Arguello D, et al: Early clinical features of dengue infection in Puerto Rico. Trans R Soc Trop Med Hyg 2009; 103:878-884
50. Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596
51. Mellor DH: The place of computed tomography and lumbar puncture in suspected bacterial meningitis. Arch Dis Child 1992; 67: 1417-1419
52. De Paula SO, Pires Neto RJ, Correa JA, et al: The use of reverse transcription-polymerase chain reaction (RT-PCR) for the rapid detection and identification of dengue virus in an endemic region: A validation study. Trans R Soc Trop Med Hyg 2002; 96:266-269
53. Dussart P, Labeau B, Lagathu G, et al: Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin Vaccine Immunol 2006; 13: 1185-1189
54. Chakravarti A, Gur R, Berry N, et al: Evaluation of three commercially available kits for serological diagnosis of dengue haemor-rhagic fever. Diagn Microbiol Infect Dis 2000; 36:273-274
55. Colbert JA, Gordon A, Roxelin R, et al: Ultrasound measurement of gallbladder wall thickening as a diagnostic test and prognostic indicator for severe dengue in pediatric patients. Pediatr Infect Dis J 2007; 26: 850-852
56. Singhi S, Khilnani P, Lodha R, et al: Guidelines for treatment of septic shock in resource limited environments. J Pediatr Infect Dis 2009; 4:173-192
57. Wills BA, Nguyen MD, Ha TL, et al: Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005; 353:877-889
58. Moxon C, Wills B: Management of severe dengue in children. Adv Exp Med Biol 2008; 609:131-144
59. Ranjit S, Kissoon N, Gandhi D, et al: Early differentiation between dengue and septic shock by comparison of admission hemody-namic, clinical, and laboratory variables: A pilot study. Pediatr Emerg Care 2007; 23: 368-375
60. Brierley J, Carcillo JA, Choong K, et al: Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009; 37:666-688
61. Lum LC, Abdel-Latif Mel-A, Goh AY, et al: Preventive transfusion in dengue shock syndrome: Is it necessary? J Pediatr 2003; 143: 682-684
62. de Castro RA, de Castro JA, Barez MY, et al: Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration of anti-D (Rh(0)-D) immune globulin. Am J Trop Med Hyg 2007; 76: 737-742
63. Rajapakse S: Intravenous immunoglobulins in the treatment of dengue illness. Trans R Soc Trop Med Hyg 2009; 103:867-870
64. Chuansumrit A, Wangruangsatid S, Lektr-akul Y, et al: Control of bleeding in children with dengue hemorrhagic fever using recom-binant activated factor VII: A randomized, double-blind, placebo-controlled study. Blood Coagul Fibrinolysis 2005; 16:549-555
65. Cam BV, Tuan DT, Fonsmark L, et al: Randomized comparison of oxygen mask treatment vs. nasal continuous positive airway pressure in dengue shock syndrome with acute respiratory failure. J Trop Pediatr 2002; 48:335-339
66. Carlotti AP, Carvalho WB: Abdominal compartment syndrome: A review. Pediatr Crit Care Med 2009; 10:115-120
67. Clinical Practice Guideline on Management of Dengue in Adults. Second Edition. 2008. Available at: http://www.moh.gov.my. Accessed October 25, 2009
68. Myo-Khin, Soe-Thein, Thein-Thein-Myint, et al: Serum cortisol levels in children with dengue haemorrhagic fever. J Trop Pediatr 1995; 41:295-297
69. Panpanich R, Sornchai P, Kanjanaratana-korn K: Corticosteroids for treating dengue shock syndrome. Cochrane Database Syst Rev. 2006; 3:CD003488
70. Cherian T, Ponnuraj E, Kuruvilla T, et al: An epidemic of dengue haemorrhagic fever & dengue shock syndrome in & around Vellore. Indian J Med Res 1994; 100:51-56
71. Rothman AL: UpToDate May 2008. Prevention and treatment of dengue virus infection UpToDate 2008. Available at http://www. Uptodate.com. Accessed September 2008
72. Monath TP: Dengue and yellow fever: Challenges for the development and use of vaccines. N Engl J Med 2007; 357:2222-2225
73. Sabchareon A, Lang J, Chanthavanich P, et al: Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five-to twelve-year-old Thai children. Pediatr Infect Dis J 2004; 23:99-109